Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04927845 · ClinicalTrials.gov registry record · NA
StriveWeekly Online Mental Health Trial Post-pandemic
A NA study, sponsored by Harvard University.
- Completed
- Registry status
- NA
- Development phase
- 538
- Enrollment target
NCT04927845 is a NA study that has completed, run by Harvard University. The registered enrollment target is 538 participants.
The verdict
NCT04927845, a NA study, has completed, sponsored by Harvard University.
- COMPLETED
- Registry status
- NA
- Development phase
- 538 participants
- Enrollment target
Study Summary
With the COVID-19 pandemic completely altering the landscape of higher education, students have been experiencing more stress than ever. With Harvard University's plan for students to return to campus for the 2021-2022 academic year, offering an online mental health program such as StriveWeekly could provide students with stress management support as they transition back after 1.5 years of remote learning. This study will use a randomized controlled trial design to test the effectiveness of a waitlist versus StriveWeekly. This study will allow us to test if a program that has previously demonstrated effectiveness with university students in reducing anxiety and depression symptoms will still be effective after the unprecedented amount of stressors during a global pandemic. Primary aim: We aim to evaluate the effectiveness of StriveWeekly in preventing or reducing symptoms of anxiety and depression. The use of a waitlist condition will allow us to experimentally assess if the online intervention is responsible for decreasing / preventing worsened anxiety, depression, and stress symptoms over time. Given the previously established effectiveness of StriveWeekly as an indicated prevention program, we expect students in the intervention condition to experience significantly better symptoms compared to the waitlist from baseline to posttest. Alternatively, if the transition back from remote learning and/or the broad pandemic context interferes with the acceptability or effectiveness of StriveWeekly, then we might expect to see little to no significant differences between the online intervention condition and waitlist condition from baseline to posttest. Secondary aims include: (a) testing moderators of intervention effectiveness and (b) evaluating the intervention in terms of acceptability (e.g., feedback on program name; demographically representativeness of student user sample; satisfactory adherence and satisfaction rates). Exploratory moderation analyses across grou
Interventions
- BEHAVIORAL StriveWeekly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 538 participants |
| Start Date | 2021-05-19 |
| Est. Completion | 2022-06-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04927845
The ClinicalTrials.gov registry entry for NCT04927845 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 538 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which StriveWeekly is the first listed.
NCT04927845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04927845 about?
NCT04927845 is a clinical study titled "StriveWeekly Online Mental Health Trial Post-pandemic". With the COVID-19 pandemic completely altering the landscape of higher education, students have been experiencing more stress than ever. With Harvard University's plan for students to return to campus for the 2021-2022 academic year, offering an online mental health program such as StriveWeekly coul...
What is the current status of trial NCT04927845?
This trial is currently completed. It is a NA study. The enrollment target is 538 participants. The study started on 2021-05-19. Estimated completion is 2022-06-10.
What interventions are being tested in trial NCT04927845?
The interventions under investigation include: StriveWeekly (BEHAVIORAL).
Who is sponsoring clinical trial NCT04927845?
This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.